Dr. Cagney is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
450 Brookline Ave
Boston, MA 02215Phone+1 617-632-3000Fax+1 617-632-4773
Summary
- Dr. Daniel Cagney is a radiation oncologist in Boston, MA and is affiliated with multiple hospitals in the area, including Dana-Farber Cancer Institute and Brigham and Women's Hospital. He received his medical degree from University College Cork Faculty of Medicine and has been in practice 12 years. He is experienced in stereotactic radiosurgery, intensity-modulated radiation therapy, radiosurgery, and stereotactic body radiotherapy.
Education & Training
Brigham and Women's Hospital/Massachusetts General Hospital/Harvard Medical SchoolFellowship, Radiation Oncology, 2015 - 2017
Newcastle UniversityMSc, Oncology and Palliative Care, 2014 - 2017
University College Cork Faculty of MedicineClass of 2006, MB BCh BAO BMedSci
Certifications & Licensure
MA State Medical License 2018 - 2025
American Board of Radiology Radiation Oncology
Awards, Honors, & Recognition
- St. Luke's Institute of Cancer Research Fellowship SLICR, Dublin, Ireland, 2016
- Richard Steevens Scholarship Health Services Executive, Ireland, 2015
Clinical Trials
- Stereotactic Magnetic Resonance Guided Radiation Therapy Start of enrollment: 2019 Oct 22
- CONFIRM: Magnetic Resonance Guided Radiation Therapy Start of enrollment: 2021 May 01
- Nano-SMART: Nanoparticles With MR Guided SBRT in Centrally Located Lung Tumors and Pancreatic Cancer Start of enrollment: 2021 May 27
Publications & Presentations
PubMed
- The use of master protocols for efficient trial design to evaluate radiotherapy interventions: a systematic review.Alexandra Gilbert, Robert Samuel, Daniel Cagney, David Sebag-Montefiore, Julia Brown
Journal of the National Cancer Institute. 2024-08-01 - 6 citationsStereotactic Magnetic Resonance-guided Adaptive Radiation Therapy for Localized Kidney Cancer: Early Outcomes from a Prospective Phase 1 Trial and Supplemental Cohort.Kendrick Yim, Shu-Hui Hsu, José Ignacio Nolazco, Daniel Cagney, Raymond H Mak
European Urology Oncology. 2024-02-01 - 4 citationsWidening the therapeutic window for central and ultra-central thoracic oligometastatic disease with stereotactic MR-guided adaptive radiation therapy (SMART).Grace Lee, Zhaohui Han, Elizabeth Huynh, Michael C Tjong, Daniel N Cagney
Radiotherapy and Oncology. 2024-01-01
Journal Articles
- Original Article Neurosurgical Resection and Stereotactic Radiation Versus Stereotactic Radiation Alone in Patients with a Single or Solitary Brain MetastasisJohn G Phillips, Itai M Pashtan, Ayal A Aizer, Elizabeth B Claus, Shyam K Tanguturi, Daniel N Cagney, Brian M Alexander, Nayan Lamba, Alexandra J Golby, ScienceDirect
Authored Content
- HMS Global Academy MRI-Guided Radiation: The Future is Now.12/11/2017
Press Mentions
A New Machine to Improve Radiation OncologySeptember 30th, 2019
Characteristics and Screening of Brain Metastases in Breast Cancer and NSCLCJune 14th, 2018
Screening for Brain Mets Could Improve Quality of Life for Some with Breast CancerMay 24th, 2018- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
